Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142659 |
| CAS No | NA |
| Mol.F. | C7H7ClN4O6S2 |
| Mol.Wt. | 342.73 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142660 |
| CAS No | NA |
| Mol.F. | C17H14N6O2 |
| Mol.Wt. | 334.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142661 |
| CAS No | NA |
| Mol.F. | C28H20ClF3N8O2 |
| Mol.Wt. | 592.97 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142662 |
| CAS No | NA |
| Mol.F. | C29H23F3N8O2 |
| Mol.Wt. | 572.55 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142663 |
| CAS No | NA |
| Mol.F. | C18H15N5O3 |
| Mol.Wt. | 349.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142664 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O2 |
| Mol.Wt. | 558.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142665 |
| CAS No | NA |
| Mol.F. | C20H18F3N7O2 |
| Mol.Wt. | 445.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142666 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.52g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142667 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O4 |
| Mol.Wt. | 590.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142668 |
| CAS No | NA |
| Mol.F. | C19H19N5O2 |
| Mol.Wt. | 349.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142669 |
| CAS No | NA |
| Mol.F. | C37H27F3N12O2 |
| Mol.Wt. | 728.70 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142670 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142671 |
| CAS No | NA |
| Mol.F. | C19H14F3IN4O2 |
| Mol.Wt. | 514.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142672 |
| CAS No | NA |
| Mol.F. | C21H21N5O3 |
| Mol.Wt. | 391.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142673 |
| CAS No | NA |
| Mol.F. | C15H11N3O3 |
| Mol.Wt. | 281.27 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142674 |
| CAS No | NA |
| Mol.F. | C15H14ClN3O2 |
| Mol.Wt. | 303.75 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |